Valuation: Perrigo Company

Market Cap 2.13B 1.91B 1.78B 1.61B 3.03B 202B 3.05B 21.27B 8.33B 105B 8.01B 7.83B 338B P/E 2026 *
1,537x
P/E 2027 * 12.8x
Enterprise Value 5.04B 4.5B 4.19B 3.8B 7.16B 478B 7.21B 50.25B 19.67B 249B 18.92B 18.5B 798B EV / Sales 2026 *
1.24x
EV / Sales 2027 * 1.2x
Free-Float
99.61%
Yield 2026 *
7.53%
Yield 2027 * 7.72%
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%+0.78%+42.36%+91.48% 1,040B
-5.73%-2.42%+30.23%+58.50% 599B
-2.40%+2.88%+19.13%+85.43% 485B
-2.39%+0.03%+65.67%+36.51% 350B
+0.28%+0.28%+26.14%+43.17% 345B
+0.42%-0.23%+15.09%+37.32% 272B
-0.17%-2.51%-6.78%+8.22% 244B
-1.13%+2.54%+41.19%+45.32% 223B
-1.67%+2.56%+25.13%+90.50% 183B
Average -1.26%+2.38%+28.68%+55.16% 415.87B
Weighted average by Cap. -1.16%+2.31%+31.99%+63.63%

Financials

2026 *2027 *
Net sales 4.06B 3.63B 3.38B 3.06B 5.77B 385B 5.81B 40.49B 15.85B 200B 15.25B 14.91B 643B 4.09B 3.65B 3.4B 3.09B 5.81B 388B 5.86B 40.79B 15.97B 202B 15.36B 15.02B 648B
Net income -224M -200M -187M -169M -318M -21.27B -321M -2.24B -875M -11.06B -842M -823M -35.5B -56.95M -50.87M -47.42M -42.99M -80.91M -5.41B -81.54M -568M -222M -2.81B -214M -209M -9.02B
Net Debt 2.9B 2.59B 2.42B 2.19B 4.13B 276B 4.16B 28.97B 11.34B 143B 10.91B 10.67B 460B 2.78B 2.49B 2.32B 2.1B 3.95B 264B 3.99B 27.77B 10.87B 137B 10.45B 10.23B 441B
Logo Perrigo Company
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Perrigo Company